RT Journal Article
SR Electronic
T1 THE G-FORCE CONUNDRUM IN PRF GENERATION- MANAGEMENT OF A PROBLEM HIDDEN IN PLAIN SIGHT
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.29.20084251
DO 10.1101/2020.04.29.20084251
A1 Sneha, Kidambi
A1 Ajmera, Jhansi Rani
A1 Chandra, Rampalli Viswa
YR 2020
UL http://medrxiv.org/content/early/2020/05/05/2020.04.29.20084251.abstract
AB Aim A force of 400g at 2700 RPM results in an optimum leucocyte and platelet-rich fibrin (L-PRF). Most of centrifuges with varying characteristics generate a g-force in excess of 700g at 2700 RPM. In this context, the study explores the effect of the original centrifugation protocol and a modified protocol tailor-made to lower the RPM to generate a g-force of ~400g on platelet concentration, clot size and growth factors release in L-PRF prepared in two different commercially available centrifuges.Materials and Methods 25 subjects each were assigned to the following groups; R1 and R2 where L-PRF was obtained from two laboratory swing-out centrifuges (Remi 8C® & Remi C854®, Mumbai, India) respectively. PRF was obtained from each subject within a group using two protocols; Original (O) protocol: conforming to the original centrifugation cycle (2700 RPM for 12 min) and Modified (M) protocol. Clot size, growth factor estimation and platelet counts were measured at 20, 40 and 60 mins from all the L-PRF clots.Results At the third time period (40–60min), there were no significant differences in clot sizes with the original protocol (p=0.09), but a highly significant difference was noticed with the modified protocol in both the centrifuges (p=0.001). Our results showed an increased concentration of VEGF and EGF with modified protocol than with original protocol with both the centrifuges (p=0.001). By the end of second and third time periods, more platelet concentration was observed with modified protocol than with the original protocol in both the centrifuges (p=0.001)Conclusion This study infers that the centrifuge type and RCF can affect the quality and quantity of cells and growth factors and an optimum relationship between g-force and RPM should be maintained in order to obtain L-PRF with adequate cell viability and optimum growth factor release.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThe study was basically an in-vitro trial performed by using blood from human subjects. It did not involve any therapy or treatment on human subjects.Funding StatementThis study was supported by the author's own institution and no external funding was received.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available on request and enquiries can be sent to svsperiodontology{at}gmail.com